AGANTRYS (registration number 5202476) is a United States trademark of DAIICHI SANKYO COMPANY, LIMITED. The goods and services are: Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease . The correspondent is TANIYAMA Takashi.
This trademark was filed on September 20, 2016 as United States Trademark Application Serial Number 79200076.
Trademark PTO Status
20220703 – NEW REPRESENTATIVE AT IB RECEIVED
20180423 – REVIEW OF CORRESPONDENCE COMPLETE – CERTIFICATE OF REG MAILED
20170714 – NOTIFICATION PROCESSED BY IB
20170624 – FINAL DISPOSITION NOTICE SENT TO IB
20170624 – FINAL DISPOSITION PROCESSED
20170615 – GRANT OF PROTECTION CREATED, TO BE SENT TO IB
20170516 – REGISTERED-PRINCIPAL REGISTER
20170311 – NOTIFICATION PROCESSED BY IB
Ownership History
DAIICHI SANKYO COMPANY, LIMITED
DAIICHI SANKYO COMPANY, LIMITED
DAIICHI SANKYO COMPANY, LIMITED
File a Trademark
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.